Denosumab Favored Over Alendronate for BMD Protection ...Middle East

News by : (Medscape) -
"Glucocorticoids remain the mainstay of treatment of rheumatic diseases, but [they are] a major risk factor for osteoporosis and fracture." Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Denosumab Favored Over Alendronate for BMD Protection )

Also on site :

Most Viewed News
جديد الاخبار